MolnupiravirLack of efficacy and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57639-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：546 / 546

相关论文

共 50 条

[41] Multiple drugsDelirium, lack of efficacy and off-label use
Reactions Weekly, 2024, 2006 (1) : 426 - 426
[42] HydroxychloroquineLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1925 (1) : 264 - 264
[43] AzithromycinLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1878 (1) : 110 - 110
[44] DOFETILIDE EFFICACY AND SAFETY PROFILE IN OFF-LABEL USE
Brumberg, Genevieve E.
Gera, Nitin
Adelstein, Evan
Saba, Samir
Jain, Sandeep
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E683 - E683
[45] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1943 (1) : 84 - 84
[46] SertralineLack of efficacy and off-label use: case report
Reactions Weekly, 2023, 1938 (1) : 1156 - 1156
[47] MethylprednisoloneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1934 (1) : 275 - 275
[48] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1895 (1) : 165 - 165
[49] AntineoplasticsLack of efficacy and off-label use: case report
Reactions Weekly, 2021, 1871 (1) : 52 - 52
[50] DexamethasoneLack of efficacy and off-label use: case report
Reactions Weekly, 2022, 1906 (1) : 166 - 166

← 1 2 3 4 5 →